About ReadyGo
ReadyGo is a company based in Bath (United Kingdom) founded in 2020 by Ben Cobb, Mike Catt, Alex Clarkson, and Elaine Warburton. ReadyGo has raised $3.89 million across 4 funding rounds from investors including British Business Bank. ReadyGo offers products and services including snapcollect, Snapshot, Geo™, and Flex™. ReadyGo operates in a competitive market with competitors including Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
- Headquarter Bath, United Kingdom
- Founders Ben Cobb, Mike Catt, Alex Clarkson, Elaine Warburton
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Readygo Diagnostics Limited
- Date of Incorporation 12 Jan, 2016
- Jurisdiction BEDFORD, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.89 M (USD)
in 4 rounds
-
Latest Funding Round
$644.51 K (USD), Seed
Mar 07, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ReadyGo
ReadyGo offers a comprehensive portfolio of products and services, including snapcollect, Snapshot, Geo™, and Flex™.
Tool for simple and efficient diagnostic sample collection.
Platform for decentralized sample collection and testing.
Innovative platform for molecular diagnostic testing.
System for designing low-cost, rapid diagnostic assays.
Funding Insights of ReadyGo
ReadyGo has successfully raised a total of $3.89M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $644.51 thousand completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ReadyGo
ReadyGo has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include British Business Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt fund and fund of funds focused on startups
|
Locked | Locked | Locked |
Investor details for ReadyGo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ReadyGo
Investment portfolio details for ReadyGo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ReadyGo
Detailed financials for ReadyGo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Readygo Comparisons
Peer comparison for ReadyGo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ReadyGo
ReadyGo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| Locked | Locked | Locked |
Miniaturized MRI platforms for clinical diagnostics are developed.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
Detailed competitors of ReadyGo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Readygo
Complete news archive for ReadyGo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ReadyGo
ReadyGo was founded in 2020 and raised its 1st funding round 1 year after it was founded.
ReadyGo is headquartered in Bath, United Kingdom. It is registered at Bath, Somerset, United Kingdom.
Ben Cobb is the current CEO of ReadyGo. They have also founded this company.
ReadyGo is a funded company, having raised a total of $3.89M across 4 funding rounds to date.
ReadyGo was founded in 2020 and is based in Bath, United Kingdom. Diagnostic test and sample collection tools are supplied by the company to research labs. The product lineup includes Snap for sample collection and Snapshot for diagnostic testing. A rapid test platform is also offered to support small laboratories, pharmacies, and off-grid diagnostic needs within the healthcare sector.
ReadyGo's top competitors include Visby Medical, Inflammatix and MeMed.
ReadyGo offers snapcollect, Snapshot, Geo™, and Flex™.
ReadyGo has 1 investor. Key investors include British Business Bank.